Live News EARNINGS ARTICLE L impact Aug 05, 2026, 08:32 PM UTC

Emergent BioSolutions Lowers FY2026 Sales Guidance from $720.000M-$760.000M to $645.000M-$675.000M vs $733.050M Est

Emergent BioSolutions (NYSE: EBS ) lowers FY2026 sales outlook from $720.000 million-$760.000 million to $645.000 million-$675.000 million vs $733.050 million estimate.

EBS

SquawkNews Newsroom

Emergent BioSolutions (NYSE: EBS ) lowers FY2026 sales outlook from $720.000 million-$760.000 million to $645.000 million-$675.000 million vs $733.050 million estimate.